Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

In The Lancet Diabetes & Endocrinology, Jing Luo and colleagues present the HumAn-1 trial, an important contribution to the literature on type 1 diabetes in low-income and middle-income countries ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

The world's first large-scale artificial pancreas rollout has delivered promising results, helping people with type 1 ...

A new therapy for type 1 diabetes could nix the need for insulin injections. Just a single infusion of lab-grown pancreatic cells let patients’ bodies make all the insulin they needed, scientists ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning point. The company confirms its status as a global reference partner for ...

People with type 1 or insulin-requiring type 2 diabetes in the U.S. can now wear MiniMed's smallest pump, paired with the ...

Please provide your email address to receive an email when new articles are posted on . All hybrid closed-loop systems improved time in range and time below range compared with other insulin therapies ...

Share on Pinterest Mounjaro appears to be a safe and effective adjunct therapy to slow-release insulin for treating uncontrolled diabetes. Mohammed Al Ali/Shutterstock Tirzepatide, Mounjaro, is ...

Leo, a 22-year-old man who received a diagnosis of type 1 diabetes at 17 years of age, has struggled to meet glucose targets. As a young adult, he has many competing priorities, and diabetes is not ...